SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193805-08-000592
Filing Date
2008-02-14
Accepted
2008-02-14 11:18:34
Documents
1
Group Members
DEERFIELD CAPITAL, L.P.DEERFIELD INTERNATIONAL LIMITEDDEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD PARTNERS, L.P.DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LIMITEDDEERFIELD SPECIAL SITUATIONS FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 e603333_13ga-poniard.txt SC 13G/A 31874
  Complete submission text file 0001193805-08-000592.txt   34188
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 7000 SHORELINE COURT SUITE 270 SO. SAN FRANCISCO CA 94080 2062817001
PONIARD PHARMACEUTICALS, INC. (Subject) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-40119 | Film No.: 08609953
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address 212-551-1600
Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13G/A